FDA issues PML warning for MS patients taking Gilenya
Posted: Wed Aug 05, 2015 4:11 am
Following reports of progressive multifocal leukoencephalopathy among patients taking Gilenya for multiple sclerosis, the FDA has issued a warning of possible infection for those prescribed the immunosuppressant drug.... Read More - http://www.ms-uk.org/gilenya